Physician

Iliana L Cardona Orellana, M.D.

According to 2025 Medicare claims, Iliana Orellana, M.D. (NPI: 1538475983) practices nephrology in the Eagle Pass, TX market, with the plurality of this provider's patient population coming from Maverick, TX. This provider's primary affiliated billing organization is RENAL ASSOCIATES, P.A. (NPI: 1851368112; TIN: 742083988) and primary practice location at 78852-5884. Orellana is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Orellana's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 340 traditional Medicare patients, billed 1,763 HCPCS/CPT codes, and received $136,271 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 899 prescription claims across 162 beneficiaries totaling $516,173 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2023 DME data shows 62 claims. Open Payments data shows 35 records totaling $817. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $370,180 to $136,271. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $190,779 and ending at $516,173. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	595	5,432	$370,180
2016	685	8,248	$520,017
2017	718	9,137	$541,391
2018	674	10,047	$510,292
2019	662	9,321	$513,048
2020	611	7,214	$438,346
2021	563	2,857	$272,213
2022	425	2,719	$230,308
2023	391	2,112	$178,793
2024	340	1,763	$136,271

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	276	1,704	$190,779
2016	471	3,842	$486,595
2017	492	3,746	$1,109,687
2018	456	2,658	$755,514
2019	437	2,468	$711,932
2020	439	2,581	$1,006,738
2021	307	1,655	$484,748
2022	197	1,121	$315,238
2023	183	1,092	$399,876
2024	162	899	$516,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	23	182	$6,485
2016	51	500	$15,437
2017	50	511	$14,267
2018	44	526	$15,842
2019	43	425	$12,211
2020	42	457	$14,710
2021	N/R	291	$7,317
2022	N/R	93	$1,483
2023	N/R	62	$1,493
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	60	61	$113
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	122	294	$82
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	194	$81
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	66	122	$54
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	48	282	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	80	2,460	$173,860
Mounjaro	Tirzepatide	50	1,458	$53,444
Jardiance	Empagliflozin	35	2,190	$41,061
Auryxia	Ferric Citrate	11	750	$26,524
Sevelamer Carbonate	Sevelamer Carbonate	72	4,680	$16,253

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$817	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Iliana L. Cardona Orellana, M.D.?

Tedicare shows public-source Medicare data for Iliana L. Cardona Orellana, M.D. (NPI 1538475983), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Iliana L. Cardona Orellana, M.D. have ACO affiliation data?

Iliana L. Cardona Orellana, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Iliana L. Cardona Orellana, M.D.?

Iliana L. Cardona Orellana, M.D. is linked to RENAL ASSOCIATES, P.A. (billing NPI 1851368112) in the available physician profile data.

Does Iliana L. Cardona Orellana, M.D. have Open Payments data?

Iliana L. Cardona Orellana, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.